Full-Time

Sr. Staff QMS Specialist

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Global medical technology and diagnostics provider

Compensation Overview

$155.9k - $257.3k/yr

Senior

San Diego, CA, USA

This position is a temporary assignment and is anticipated to last approximately through March 2026. The job requires a minimum of 4 days of in-office presence per week.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Risk Management
Data Analysis
Requirements
  • Bachelor of Arts (BA), Bachelor of Science (BS) in related field
  • Minimum of 8 years experience with emphasis on participating and leading projects within Medical Device QMS space
  • Strong knowledge of quality management systems and industry related regulations (FDA 21 CFR 820, ISO 13485, MDSAP, ISO 9001)
  • Strong interpersonal skills including decision making, persuasion, effective communication, objectivity, assertiveness, and thoroughness
  • Ability to implement processes and systems
  • Excellent ability to apply a systematic and analytical approach to problem solving
  • Ability to create, write, and present material, adjusting to the level of the audience
  • Knowledge and experience in process analysis, root cause investigation and risk management
  • Ability to develop solutions and effectively collaborate with all levels of staff while maintaining an appropriate assertive style
  • Effective project management and organizational skills
  • Ability to influence without authority coupled with ability to work collaboratively and effectively communicate with peers and management across all functions
  • Considered Site / functional level Subject Matter Expert in assigned areas of Quality Systems
Responsibilities
  • Responsible for managing all aspects of Quality Planning to ensure timely completion of deliverables and closure of Quality Plans
  • Proactively engage stakeholders to drive consensus and resolve issues in a timely fashion
  • Knowledgeable in verification/ validation process, risk management, design controls, and quality compliance areas to drive technical discussions and remove roadblocks
  • Take a leading role in the development, implementation and maintenance of Quality System processes required for compliance to FDA 21 CFR 820, MDSAP, ISO 13485, and ISO 9001
  • Work collaboratively with functional teams to guide and/or facilitate QMS requirements, Continuous Improvement, and Audit Support
  • Facilitate Continuous Improvement projects and investigations including data analysis, root cause analysis and development of action plans to support the QMS
  • Coordinate or lead Quality related projects
  • Maintain and manage positive working relationships both vertically and horizontally within the organization while leading and/or assisting in all stages of Quality Management System activity and projects
  • Participate or lead other Quality and Transition Projects
Desired Qualifications
  • Software development experience within a regulated environment is preferred

BD (Becton, Dickinson and Company) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on medication management and delivery; BD Life Sciences, which offers products for safe collection and transport of diagnostic specimens; and BD Interventional, which provides devices for minimally invasive surgeries. The company generates revenue by selling medical devices, laboratory equipment, and diagnostic products. BD stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare.

Company Size

10,001+

Company Stage

IPO

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...